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Abstract
Background: To investigate the possible effects of different levels of attributes of a point-of-care test (POCT) on sexually
transmitted infection (STI) professionals’ decisions regarding an ideal POCT for STI(s).
Methods: An online survey was designed based on a large-scale in-depth focus discussion study among STI experts and
professionals. The last section of the survey ‘‘build your own POCT’’ was designed by employing the discrete choice
experiment approach. Practicing clinicians from two venues, STI-related international conference attendees and U.S. STD
clinic clinicians were invited to participate in the survey. Conditional logistical regression modeling was used for data
analysis.
Results: Overall, 256 subjects took the online survey with 218 (85%) completing it. Most of the participants were STD clinic
clinicians who already used some POCTs in their practice. ‘‘The time frame required’’ was identified as a major barrier that
currently made it difficult to use STI POCTs. Chlamydia trachomatis was the organism chosen as the top priority for a new
POCT, followed by a test that would diagnose early seroconversion for HIV, and a syphilis POCT. Without regard to organism
type selected, sensitivity of 90–99% was always the most important attribute to be considered, followed by a cost of $20.
However, when the test platform was prioritized for early HIV seroconversion or syphilis, sensitivity was still ranked as most
important, but specificity was rated second most important.
Conclusions: STI professionals preferred C. trachomatis as the top priority for a new POCT with sensitivity over 90%, low
cost, and a very short completion time.
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Introduction
Sexually transmitted infections (STIs), the leading group of
reportable diseases in the United States each year, have an estimate
of approximately 20 million new cases [1] and more than 10 billion
dollars in costs each year [2]. A good point-of-care test (POCT) for
STI(s) which may offer immediate diagnosis and prompt treatment
could effectively reduce prevalence and transmission in communi-
ties. World Health Organization Sexually Transmitted Diseases
Diagnostics Initiative (WHO SDI) has identified the following test
criteria as benchmarks for a POCT for STI(s) which would have the
ability to address some of STI control needs: Affordable, Sensitive,
Specific, User-friendly, Rapid and robust, Equipment-free and
Deliverable to end-users (ASSURED) [3,4].
A recent large-scale in-depth focus group discussion study
among STI experts and professionals showed that high
sensitivity and specificity, quick turn-around time, and low cost
were the most important characteristics for an ideal POCT for
STIs [5]. However, in reality, a diagnostic test may not possess
a l lo ft h e s ei d e a la t t r i b u t e st h a teveryone desires. Little is known
about which characteristics STI professionals value over others
when they are forced to choose between different diagnostic
characteristics that have significant advantages and disadvan-
tages. Choice questions that vary attributes can measure how
STI professionals would ‘trade off’ different level of sensitivity,
specificity, cost, and time for a test, i.e. prefer one test over
another another test, each having a defined set set of values and
characteristics.
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marketing research in the early 1970s as an attribute-based
measure methodology which gauges individual’s evaluation on
levels of attributes/characteristics of a service, policy, intervention,
or a diagnostic test for decision-making [6,7]. This approach is
increasingly applied in health care and health economics research
[8,9,10]. Our goal was to investigate the possible effects of different
levels of attributes of POCT, including sensitivity, specificity, turn-
around time, and cost, on STI professionals’ decisions regarding
an ideal POCT for STI(s) by employing the discrete-choice
experimental approach.
Materials and Methods
Ethical Statement
This study protocol was approved by Institutional Review Board
(IRB) of The Johns Hopkins University School of Medicine. Due to
the nature of our online survey study design as well as the research
presented no more than minimal risk to subjects, verbal or
conventional written consent was not obtained per The Johns
Hopkins University School of Medicine IRB approval. We also
included a written disclosure describing the study in the beginning
ofthe survey.Subjectswereabletoterminatethesurveyatanytime.
Study Population/Recruitment
A list of all categorical STI clinics throughout the ten federally
funded regions of the United States was provided by the Centers
for Disease Control and Prevention. The list was validated by
research assistants who divided the list according to region and
telephoned each designated listed clinic manager within the
assigned regions to invite them to participate in the online survey.
Each manager was asked to distribute an invitation letter to all of
their clinicians to also participate in the online survey (in the hope
that clinicians would be more likely to take the survey if it were
recommended by a co-worker). An IRB-approved invitation letter
and a thank you e-mail were then sent to each agreeable clinic
manager. We were able to contact over 700 clinics offering STI
care and collected information from over 200 respondents. In
addition to the U.S. based participants, we further recruited survey
participants via in-person outreach among attendees at two
international conferences: the International Society for Sexually
Transmitted Diseases Research (ISSTDR) conference held in
London (June 2009) and the Infectious Diseases Society for
Obstetrics and Gynecology in Montreal (August 2009).
Survey Tool
The survey (Appendix S1) was developed based on the findings
from our formative assessment project which identified the need
for and perception of qualities imperative for an ideal new STI
POCT [5]. Our survey contained the following elements: (1)
demographics, including gender, country of practice, profession,
type of practice; (2) currently available POCTs and unique
barriers of use; (3) ideal future type of POCT for STI(s), including
prioritizing the pathogens for development and economic factors;
and (4) a section called ‘‘build your own POCT’’ - preference of
POCT for STI(s) with different levels of sensitivity, specificity,
turn-around time, and cost. The last part of the survey was
designed using the discrete choice experiment approach. We used
3 levels of sensitivity (70–79%, 80–89%, $90%), 3 levels of
specificity (90%, 95%, 99%), 3 levels of turn-around time
(5 minutes, 15 minutes, 25 minutes), and 3 levels of cost ($20,
$35, $50) to randomly create 16 choice questions. Each of the
choice questions contained a pair of POCTs with different sets of
attributes for participants to select their preferred diagnostic from
the pair. The survey was placed on Survey Monkey (SurveyMon-
key.com, Portland, OR) after several rounds of pre-tests of the
survey tool.
Data Analysis
Data were described using frequencies and percentages as
appropriate. In the ‘‘build your own POCT’’ section of survey
data, the probability of individuals making a particular choice
from presented alternatives were estimated by choice modeling
which is a type of conditional logistic regression. Odds ratios were
calculated from regression coefficients for all attributes. Subgroup
analyses of choice modeling were performed for each of top three
prioritized pathogens for new STI POCT chosen by the
participants, as well as profession (medical director versus and
non medical director) and geographical region (U.S. versus non-
U.S.). SAS version 9.2 and JMP version 8 (SAS Institute Inc.,
Cary, NC) were used for analysis purposes. All p values were 2-
sided, with p,0.05 considered to be significant.
Results
Overall, 256 subjects took the online survey and 218 (85%)
completed the survey. There were no statistical differences in
gender, country of residency, and profession between subjects who
completed the survey and those who did not. Seventy-nine (36%)
were conference participants [ISSTDR: 52 (24%); IDSOG: 27
(12%)]. One hundred thirty-nine (64%) of participants were STD
clinic clinicians. Demographic characteristics of 218 respondents
are presented in Table 1.
The most commonly available STI POCT at participants’
clinics currently was the wet mount preparation test for the
microscopic detection of trichomonas, yeast, and ‘‘clue cells’’
(78%), i.e. saline and/or potassium hydroxide (KOH) slide
preparations of vaginal fluid for trichomonas, yeast and bacterial
vaginosis diagnosis respectively. Urine dipstick (70%) was the
second most mentioned assay, followed by the rapid HIV test
(60%), vaginal pH determination (56%), Gram Stain (48%), and
rapid syphilis test, i.e. rapid plasma reagin (RPR) (20%).
Among a list of barriers, 40% of participants identified that ‘the
time frame required’ was the most significant barrier that would
make it difficult to use currently available STI POCTs. Four other
barriers, including complexity with multiple steps (31%), interrup-
tion of work flow (30%), perceived wait time for patients (30%),
laboratory driven (30%), were reported by similar proportions of
participants.A considerablenumberofparticipants pointedout that
‘unreliability’ (23%) and ‘time-step driven’ (too many timed steps in
performance of the test) characteristics (16%) of POCT would make
it harder to use in the clinic. Fewer indicated that ‘difficulty in
reading results (10%), ‘cost’ (8%), and ‘invasiveness’ (7%) were
barriers. When being asked to select one barrier that would make it
hardest for them to use STI POCT, participants had different
opinions. Several barriers emerged as leading choices that would
make it hardest to use, including ‘laboratory driven’ (17%), ‘time
frame’(14%),‘complexity’(12%),‘unreliability’(12%), ‘interruption
of work flow’ (11%), and ‘perceived wait time for patients’ (10%).
When participants were asked to rank their top three choices for
organisms in need of a POCT for STIs, Chlamydia trachomatis was
significantly ranked as the top priority for development of new
POCT by 62% of participants (p,0.05), followed by detection of
early seroconversion of HIV infection (14%), and a POCT for
syphilis (8%). There was no statistical difference in the number of
subjects who chose HIV seroconversion and the number of those
who chose syphilis. As a second priority test, 35% of participants
chose gonorrhea followed by chlamydia (15%), HBV and/or
Desired Characteristics of an Ideal STI POC Test
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choice as third priority, followed by herpes simplex virus (19%),
and syphilis (13%).
The majority (78%) of participants believed that the cost of the
test from the manufacturer was an important factor in designing a
POCT, while less a quarter (22%) of participants believed the
amount of reimbursement received for performing the test to be
vital. Medical directors did not have different concerns in this issue
as compared to those who were not medical directors (p=0.38).
Build Your Own Test
Generally speaking, a test with a high level of sensitivity (90%)
was overwhelmingly preferred over the one with a low level of
sensitivity (70%). A test with a low level of cost ($20) was also
preferred over the one with a high level of cost ($50). Some
highlights of comparison of the individual choice question sets
were as follows. A lower level of sensitivity (70%) of POCT was
preferred over a medium level of sensitivity (80%) if it had low cost
($20) and fast turn-over-time (5 minutes) (Appendix S1 Section
‘‘Build your own test’’ – Question 3) or if it had a high level of
specificity (99%) and low cost (Appendix S1 Section ‘‘Build your
own test’’ – Question 4). The majority also thought that a high
level of sensitivity (90%) could be traded for a medium level of
sensitivity if the POCT had a higher specificity and was much
cheaper (Appendix S1 Section ‘‘Build your own test’’ – Question
5). High specificity was more important over lower specificity even
if the test was in a category higher in cost and a category slower in
time (Appendix S1 Section ‘‘Build your own test’’ – Question 14).
Using choice modeling, we found that all participants who
completed the survey selected sensitivity as their top priority issue
for a building a new STI POCT, followed by cost, specificity, and
time. They preferred the new POCT to have a sensitivity of 90–
99%, a cost of $20, a specificity of 99%, and a turn-around-time of
5 minutes (Table 2). Further subgroup analyses on top three
priorities for new POCTs based on a specific individual disease
demonstrated some differences in the perceived preference in these
4 attributes. Participants still ranked sensitivity as the leading
consideration; however, specificity became the second most
important factor for those who chose HIV seroconversion or
syphilis as their priority for a new POCT, rather than cost which
was chosen by those preferred C. trachomatis as the priority assay.
In subgroup analyses of professional differences or on
geographical regions, sensitivity was still reported as the top
priority and time was the least priority for all subgroups. However,
specificity was the second most important priority for those who
were medical directors, while cost was the second one for those
who were not medical directors (data not shown). In addition,
subjects from U.S. preferred cost as second priority issue over
specificity while cost and specificity were tied for the second
priority issue (data not shown).
Discussion
Our survey study gathered opinions on an ideal POCT for STIs
from a large group of practicing clinicians who use and would use
Table 1. Demographic Characteristics of 218 Respondents
who Participated in the Survey: ‘‘Build Your Own’’ Point-of-
Care Test.
Characteristics Categories Number (%)
N=218
Source of Participants ISSTDR 52 (23.8)
IDSOG 27 (12.4)
STD Clinics 139 (63.8)
Gender Male 48 (22.0)
Female 170 (78.0)
Country or Continent of Residence America
United States 169 (77.5)
Canada 3 (1.2)
Other 3 (1.2)
Europe
United Kingdom 16 (7.3)
Other 7 (3.2)
Asia 6 (2.8)
Africa 5 (2.2)
Oceania 2 (0.9)
Unknown 7 (3.2)
Profession Registered Nurse 85 (39.0)
Medical Director 67 (30.7)
Nurse Practitioner 22 (10.1)
Clinical Manager 11 (5.0)
Laboratory Director 8 (3.7)
Laboratory Technician 5 (2.2)
Other 20 (9.2)
Location of Practices Inner City 80 (36.7)
Rural 56 (25.7)
Non-inner City Urban 54 (24.8)
Suburban 28 (12.8)
Primary Practice Public Health Clinic 164 (75.2)
Medicaid/Medicare Provider Yes 93 (42.7)
doi:10.1371/journal.pone.0019263.t001
Table 2. Regression Analysis of the Importance of
Preferences in Attributes of a New-Point-of-Care Test for
Sexually Transmitted Infections by All Tests and by Prioritized
Tests.
Attributes Odds Ratios
ALL
N=218
Chlamydia
N=136
Early HIV
Seroconversion
N=30
Syphilis
N=21
Sensitivity (%) 90–99 13.6* 18.2* 10.6* 11.8*
80–90 4.1* 4.7* 3.1* 4.6*
70–80 1.0 1.0 1.0 1.0
Specificity (%) 99 3.7* 3.7* 4.7* 5.9*
95 2.2* 2.1* 2.4* 3.1*
90 1.0 1.0 1.0 1.0
Cost ($) 20 4.5* 5.2* 3.2* 4.3*
35 2.1* 2.3* 1.8* 2.1*
50 1.0 1.0 1.0 1.0
Time (minutes) 5 3.0* 3.2* 2.5* 3.6*
15 1.7* 1.8* 1.6* 1.9*
25 1.0 1.0 1.0 1.0
*p,0.05.
doi:10.1371/journal.pone.0019263.t002
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second phase of needs assessment for an ideal POCT for STIs
following our large-scale in-depth focus discussion study among STI
experts and professionals. This larger more extensive quantitative
survey further confirmed our findings from the qualitative focus
group discussion study [5]. In addition, it contained choice
questions to understand which characteristics STI professionals
value over others when they are forced to choose between different
diagnostic characteristics that have significant advantages and
disadvantages. Without regard to type of assay selected (i.e. all
POCTs considered together without regard to organism type),
sensitivity of 90–99% was always the most important attribute to be
considered. Our participants clearly stated what they most desired
for a POCT, which is important for manufacturers, as well as public
health officials and regulatory organizations to consider in order to
avoid developing and approving low sensitivity POCTs as van
Dommelen et al. found recently [11]. The second most important
characteristic named by participants was cost when all POCTs were
considered in aggregate, with costs or $20 or less being consistently
named in regression analysis containing all characteristics. It was
surprising that cost was such a large factor in the consideration of
attributes surveyed.
Chlamydia was the organism chosen most often as the top priority
foranewPOCT.Whenthechoicequestionanalysiswasstratifiedby
the particular type of organism chosen, the odds ratios changed
somewhat as to importance of attribute from when all types of tests
were aggregated together and are probably more important to
consider in specific test development. The difference in priority
ranking order might be due to the differential impact of false positive
result by pathogen on the subjects who receive POCT. Due to the
nature of our survey study design, we were unable to further
determine the reasons, e.g. why specificity was ranked lower than
cost by our participants who chose chlamydia as the top priority
pathogen.Furtherfuturestudiesarewarrantedtoelucidatethisissue.
‘‘Choice experiment’’ preference is a type of survey that presents
the potential user and/or buyer with a choice among several
prospective product offerings. This type of experiment can help
researchers, manufacturers, and retailers identify the most impor-
tant product attributes and assign parameter importance values to
them. By forcing choices as to combinations of different levels of
sensitivity, specificity, turn-around time, and cost to randomly
create ‘‘choice questions’’, regression analysis was able to discern
which trade-offs of choices were most important to the participants,
byusing only 16choicequestions inthesurvey. Multipleparameters
and attributes were varied in each choice question in order to
ascertain which were most important to the potential user and
which characteristics were ‘‘negotiable’’ in order to build an ideal
test, recognizing that not all perfect attributes were achievable.
Participants were forced to make choices in order to preserve what
were the most desirable features of a POCT.
Sensitivity was still the top priority for a building a new STI
POCT among 4 attributes that we investigated in this study for
participants in terms of their profession and country of residence.
However, second priority was different by profession and country
of residence. In general, medical directors in our survey might be
more concerned with false positive issue than financial issues,
resulting in their preference in specificity over cost. For those who
were not medical directors, they were more concerned with
financial issues. Reimbursement might be a more relevant issue
with testing in U.S. Therefore, participants from U.S. preferred
cost as second priority issue over specificity while the rest of world
viewed cost and specificity as evenly important.
Many barriers to routinely using POCTs for STIs were
identified by survey participants, including that ‘the time frame
required’ was the barrier that would make it difficult to use
currently available STI POCTs. Many other barriers to use were
commented on, such as the complexity with multiple steps
required, interruption of clinic work flow, perceived wait time
for patients, and requirements that the test be performed in a
laboratory rather than at the clinic office (laboratory driven). All of
these considerations could be prohibitive and could potentially be
‘‘show stoppers’’ for adoption of a new POCT, unless thought is
given to these potential problems when tests are designed. The
ranking of desired attributes of a useful POCT for STIs could
assist assay developers to design tests that meet the ASSURRED
characteristics, such that new tests will fulfill the usability criteria
[3,4].
Our study population, attendees of two STI-related interna-
tional conferences who were recruited face-to-face and U.S. STD
clinic clinicians who were recruited by phone calls and referral
from their colleagues, might be not representative to all STI
clinicians and professionals. Therefore, generalizability of our
findings could be an issue and are a limitation of this type of
approach. Nevertheless, our participants were a wide range of
types of clinicians actively working in STD clinics in different types
of practice settings from inner city to rural. More importantly, they
have already used some POCTs in their practice, making the
opinions and preferences collected from our survey study from
these current STI ‘POCT’ users imperative for the development of
new POCT for STI(s). Another potential limitation of this study is
that the potential possibility of ‘‘building your own test’’ appears to
be skewed to all ‘‘positive’’ attributes which will provide a high
degree of bias to select the highest sensitivity and specificity at the
lowest cost and shortest time, which might be technically
infeasible. However, the high degree of bias is likely avoided since
we randomly created our 16 choice set questions for ‘‘building
your own test’’ in which participants had to select one
hypothetically ‘‘imperfect’’ POCT over another ‘‘imperfect’’ one
in all but one choice sets. Finally, most of the participants were
clinical providers offering STI testing to their patients in the
frontline. They might not know that the ‘‘ideal’’ test, i.e. highest
level of sensitivity and specificity at the lowest cost and shortest
time in the choice questions, is not likely technically feasible
currently. However, their responses provide industry as well as
academia what they desired for in POCT STI when offering STI
testings for their clients. A POCT STI with these preferred ideal
characteristics might become a reality if the technology has some
breakthrough in the near future.
In summary, our study provided pilot information identifying
the need for and the preference for a set of certain attributes
among several options with different level of attributes for an ideal
new STI POCT from STI professional end users. Our findings
serve as some of latest guidance and direction of the development
of a new and ideal STI POCT for use by practitioners working in
public health, academia, and industry. Such information may be
valuable in avoiding to design a test which gives unsatisfactory
results for POC testing results [12].
Supporting Information
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